Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
Leiro-Fernandez
Virginia
V
Valverde
Diana
D
Vázquez-Gallardo
Rafael
R
Constenla
Lucía
L
Fernández-Villar
Alberto
A
D000483:Alleles; D000995:Antitubercular Agents / Q000009:adverse effects*; D001191:Arylamine N-Acetyltransferase / Q000097:blood*; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics*; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D011110:Polymorphism, Genetic; D018401:Sample Size
D000995:Antitubercular Agents; D019392:Cytochrome P-450 CYP2E1; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human